|
Gilad S. Gordon, MD, MBA is president of ORRA Group, a consulting company for the biotechnology and pharmaceutical industry which focuses on providing guidance for the clinical development of new chemical entities. Dr. Gordon helps small to medium sized organizations and universities develop their clinical trial strategies, manage their clinical development programs, fund the development programs, and submit and gain regulatory approval for their new programs and drugs. Dr. Gordon has 19 years of experience in the pharmaceutical and biotechnology fields with a primary focus on oncology, hepatology, and inflammation. Dr. Gordon received his AB from Harvard College, his MD from Harvard Medical School, and his MBA from the University of Washington. He completed his Internal Medicine residency and Board Certification at the University of Colorado Health Sciences Center and was a Robert Wood Johnson Senior Fellow at the University of Washington. Dr. Gordon is also an Attending Physician at the Denver Veterans’ Administration Medical Center. | 